- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 5.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.86M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 933.11K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.82M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $13.73M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.33M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $4.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $7.93M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.19M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.32M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.79M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $14.16M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.88M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $14.39M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.12M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.79 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.93 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.79 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.93 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.92M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.56M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.1M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.33M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.82M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.03M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.89M |